Record Information |
---|
Version | 2.0 |
---|
Created at | 2020-12-09 03:12:20 UTC |
---|
Updated at | 2021-08-19 23:59:39 UTC |
---|
NP-MRD ID | NP0006153 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Camptothecin |
---|
Provided By | NPAtlas |
---|
Description | Camptothecin is also known as CPT. Camptothecin is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Camptothecin is found in Didymochlaena truncatula, Fusarium solani, Ophiorrhiza kuroiwae, Ophiorrhiza pumila, Rinorea anguifera and Unknown-fungus sp.. Camptothecin was first documented in 2000 (PMID: 11024478). Based on a literature review a small amount of articles have been published on Camptothecin (PMID: 16378360) (PMID: 11549373) (PMID: 23344961) (PMID: 23474217). |
---|
Structure | [H]O[C@@]1(C(=O)OC([H])([H])C2=C1C([H])=C1N(C2=O)C([H])([H])C2=C([H])C3=C([H])C([H])=C([H])C([H])=C3N=C12)C([H])([H])C([H])([H])[H] InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(+)-Camptothecin | ChEBI | (+)-Camptothecine | ChEBI | (S)-(+)-Camptothecin | ChEBI | 20(S)-Camptothecine | ChEBI | 21,22-Secocamptothecin-21-Oic acid lactone | ChEBI | Camptothecine | ChEBI | CPT | ChEBI | D-Camptothecin | ChEBI | 21,22-Secocamptothecin-21-Oate lactone | Generator |
|
---|
Chemical Formula | C20H16N2O4 |
---|
Average Mass | 348.3520 Da |
---|
Monoisotopic Mass | 348.11101 Da |
---|
IUPAC Name | (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione |
---|
Traditional Name | (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=CC=CC=C4N=C13)C2=O |
---|
InChI Identifier | InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1 |
---|
InChI Key | VSJKWCGYPAHWDS-FQEVSTJZSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as camptothecins. These are heterocyclic compounds comprising a planar pentacyclic ring structure, that includes a pyrrolo[3,4-beta]-quinoline moiety (rings A, B and C), conjugated pyridone moiety (ring D) and one chiral center at position 20 within the alpha-hydroxy lactone ring with (S) configuration (the E-ring). |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Camptothecins |
---|
Sub Class | Not Available |
---|
Direct Parent | Camptothecins |
---|
Alternative Parents | |
---|
Substituents | - Camptothecin
- Pyranopyridine
- Quinoline
- Pyridinone
- Pyridine
- Benzenoid
- Heteroaromatic compound
- Tertiary alcohol
- Carboxylic acid ester
- Lactam
- Lactone
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Alcohol
- Carbonyl group
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - Puri SC, Verma V, Amna T, Qazi GN, Spiteller M: An endophytic fungus from Nothapodytes foetida that produces camptothecin. J Nat Prod. 2005 Dec;68(12):1717-9. doi: 10.1021/np0502802. [PubMed:16378360 ]
- Mosesso P, Pichierri P, Franchitto A, Palitti F: Evidence that camptothecin-induced aberrations in the G(2) phase of cell cycle of Chinese hamster ovary (CHO) cell lines is associated with transcription. Mutat Res. 2000 Sep 18;452(2):189-95. doi: 10.1016/s0027-5107(00)00083-x. [PubMed:11024478 ]
- Czuwara-Ladykowska J, Makiela B, Smith EA, Trojanowska M, Rudnicka L: The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis. Arthritis Res. 2001;3(5):311-8. doi: 10.1186/ar321. Epub 2001 Aug 2. [PubMed:11549373 ]
- Lin RK, Ho CW, Liu LF, Lyu YL: Topoisomerase IIbeta deficiency enhances camptothecin-induced apoptosis. J Biol Chem. 2013 Mar 8;288(10):7182-92. doi: 10.1074/jbc.M112.415471. Epub 2013 Jan 22. [PubMed:23344961 ]
- Ramesha BT, Suma HK, Senthilkumar U, Priti V, Ravikanth G, Vasudeva R, Kumar TR, Ganeshaiah KN, Shaanker RU: New plant sources of the anti-cancer alkaloid, camptothecine from the Icacinaceae taxa, India. Phytomedicine. 2013 Apr 15;20(6):521-7. doi: 10.1016/j.phymed.2012.12.003. Epub 2013 Mar 7. [PubMed:23474217 ]
|
---|